Skip to content

Clinical trials

Observational Metabolic Syndrome trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Metabolic Syndrome Phase: Observational Clear all

499 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20011
20024
20036
20045
200517
200612
200722
200820
200925
201019
201118
201233
201320
201426
201522
201616
201714
201816
201915
202022
202123
202219
202324
202428
202534
202628

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed237
Unknown status135
Recruiting58
Not yet recruiting34
Active, not recruiting15
Withdrawn7
Terminated6
Enrolling by invitation5
Suspended2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assiut University11
National Taiwan University Hospital10
John Sievenpiper9
University of Toronto7
Korea University5
Laval University5
AstraZeneca4
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)4
Far Eastern Memorial Hospital4
Federico II University4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Metabolic Syndrome499
Obesity151
Cardiovascular Diseases78
Diabetes Mellitus78
Insulin Resistance61
Hypertension56
Diabetes Mellitus, Type 245
Overweight41
Non-alcoholic Fatty Liver Disease32
Dyslipidemias28

Trials

Showing 26 to 50 of 499. Each trial links to its page on Pharma Observatory.

399 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.